Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

scientific article

Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.DRUGALCDEP.2010.11.004
P932PMC publication ID3069146
P698PubMed publication ID21145178
P5875ResearchGate publication ID49671143

P50authorJosé Pérez de los CobosQ52290637
Carlos BlancoQ56089029
Bridget F. GrantQ85286202
Deborah S HasinQ88070100
Mayumi OkudaQ90566067
Catalina Lopez-QuinteroQ114403697
P2093author name stringShuai Wang
P2860cites workPrevalence, Correlates, and Disability of Personality Disorders in the United StatesQ22241105
Nicotine chemistry, metabolism, kinetics and biomarkersQ24632647
The influence of DeltaFosB in the nucleus accumbens on natural reward-related behaviorQ24642930
Distinct patterns of DeltaFosB induction in brain by drugs of abuseQ24645131
Epigenetic mechanisms in drug addictionQ24645709
Disruption of the neurexin 1 gene is associated with schizophreniaQ24647095
Marijuana and cannabinoid regulation of brain reward circuitsQ24671514
The Structure of Genetic and Environmental Risk Factors for Common Psychiatric and Substance Use Disorders in Men and WomenQ28109330
From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcoholQ28211980
Psychiatric disorders and stages of smokingQ28237141
Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000-2001Q28241400
Psychiatric genetics: progress amid controversyQ28284253
Rapid induction of behavioral and neurochemical tolerance to cocaethylene, a model compound for agonist therapy of cocaine dependenceQ28372820
Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokersQ30435517
New insights into the genetics of addictionQ30435949
The role of CRF and CRF-related peptides in the dark side of addictionQ30476985
The genetic components of alcohol and nicotine co-addiction: from genes to behaviorQ30489302
Smoking, Genetics and Schizophrenia: Evidence for Self MedicationQ30491841
Pathways to adult marijuana and cocaine use: a prospective study of African Americans from age 6 to 42Q33608546
Heritability and a genome-wide linkage analysis of a Type II/B cluster construct for cannabis dependence in an American Indian communityQ33772486
Alcohol criteria endorsement and psychiatric and drug use disorders among DUI offenders: greater severity among women and multiple offendersQ33791873
Nasal mucosal versus gastrointestinal absorption of nasally administered cocaineQ33914898
Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic studyQ34220050
Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related ConditionsQ34338064
Metabolism and disposition kinetics of nicotineQ34398241
Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related ConditionsQ34456401
Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related ConditionsQ34456676
Age at onset of alcohol use and its association with DSM-IV alcohol abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic SurveyQ34459517
Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability.Q34536352
Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictionsQ34555160
Role of variability in explaining ethanol pharmacokinetics: research and forensic applicationsQ35029490
Understanding polydrug use: review of heroin and cocaine co-useQ35030844
Neurodevelopment, impulsivity, and adolescent gamblingQ35084944
"Unequal opportunity": neighbourhood disadvantage and the chance to buy illegal drugsQ35414519
Models of comorbidity for multifactorial disorders.Q35644460
Differences in onset and persistence of substance abuse and dependence among whites, blacks, and Hispanics.Q35880009
Neurobiologic processes in drug reward and addictionQ35894612
The epidemiology of dual diagnosisQ35958291
Why does the rapid delivery of drugs to the brain promote addiction?Q36024367
The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sampleQ36465741
Tobacco addictionQ36519493
Tobacco use and dependence in Asian Americans: a review of the literatureQ36761994
Adult tobacco use among racial and ethnic groups living in the United States, 2002-2005Q36790659
Nicotine metabolism in three ethnic/racial groups with different risks of lung cancerQ37008114
Neurobiology of nicotine addiction: implications for smoking cessation treatmentQ37110433
Does the 'gateway' matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication.Q37122068
Predictors of illicit substance dependence among individuals with alcohol dependenceQ37123029
The importance of timing of transitions for risk of regular smoking and nicotine dependenceQ37138256
A short review on the aetiology and pathophysiology of alcoholismQ37201073
Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefitsQ37249662
Age at first drink and the first incidence of adult-onset DSM-IV alcohol use disordersQ37384809
Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related ConditionsQ37397699
The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related ConditionsQ39742527
Surveillance of drug use among American Indian adolescents: patterns over 25 yearsQ40510169
Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: a 12-year follow-upQ40668156
Nicotine delivery kinetics and abuse liabilityQ40782278
Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity SurveyQ40992443
Multiple substance use among young malesQ43449886
Nicotine dependence in the United States: prevalence, trends, and smoking persistenceQ43730101
Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaineQ43982307
The validity of DSM-IV alcohol dependence: what do we know and what do we need to know?Q44327693
Psychiatric comorbidity of smoking and nicotine dependenceQ44484505
The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sampleQ44487795
Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adultsQ44632998
Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related ConditionsQ44634738
Cannabis use and psychosis: a longitudinal population-based study.Q44820509
Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related ConditionsQ44832144
Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and femalesQ44900954
The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sampleQ44907459
The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002.Q44934071
Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity SurveyQ44986547
Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.Q45099615
Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. populationQ45115352
Transitions from first substance use to substance use disorders in adolescence: is early onset associated with a rapid escalation?Q46392666
Heritability of substance dependence in a native American populationQ46495959
Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001.Q46535042
Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for association from a case-control studyQ46594088
Age of onset of drug use and its association with DSM-IV drug abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic SurveyQ46683000
Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Q46782998
The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population.Q47692512
Is there a progression from abuse disorders to dependence disorders?Q47907103
Male-female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcoholQ48654160
The epidemiology of DSM-IV specific phobia in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Q51763750
Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents.Q51907586
The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.Q52011224
Perceived discrimination and substance use in African American parents and their children: a panel study.Q55038322
Unfair treatment, racial/ethnic discrimination, ethnic identification, and smoking among Asian Americans in the National Latino and Asian American Study.Q55048301
Comorbidity of substance use disorders with mood and anxiety disordersQ57188031
Explaining recent increases in students' marijuana use: impacts of perceived risks and disapproval, 1976 through 1996Q57729330
Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic SurveyQ71704834
Perceived discrimination and early substance abuse among American Indian childrenQ77603957
P433issue1-2
P304page(s)120-130
P577publication date2010-12-08
P1433published inDrug and Alcohol DependenceQ5308875
P1476titleProbability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
P478volume115

Reverse relations

cites work (P2860)
Q92016219A Contagion Model for Within-Family Transmission of Drug Abuse
Q57032950A Developmental Cascade Model for Early Adolescent Onset Substance Use: The Role of Early Childhood Stress
Q88075615A Life Course Approach to Understanding Racial/Ethnic Differences in Transitions Into and Out of Alcohol Problems
Q39245261A Meta-analysis of the Effectiveness of Interactive Middle School Cannabis Prevention Programs
Q93086822A Rapid Response Electrochemical Biosensor for Detecting Thc In Saliva
Q58088419A Survey of Cannabis Acute Effects and Withdrawal Symptoms: Differential Responses Across User Types and Age
Q64284395A commentary on the medicinal use of marijuana
Q40485915A longitudinal study predicting adolescent tobacco, alcohol, and cannabis use by behavioral characteristics of close friends.
Q37157966A multistep general theory of transition to addiction.
Q38804078A review of epidemiologic research on smoking behavior among persons with alcohol and illicit substance use disorders
Q39286561Addiction as a BAD, a Behavioral Allocation Disorder.
Q58734455Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood
Q26861513Adverse health effects of marijuana use
Q88438176Age of Cannabis Use Onset and Adult Drug Abuse Symptoms: A Prospective Study of Common Risk Factors and Indirect Effects
Q53765984Age of initiation and substance use progression: A multivariate latent growth analysis.
Q37164860Alcohol problems as a signal for sensitivity to nicotine dependence and future smoking
Q47568308Aligning the ICD-11 classification of disorders due to substance use with global service needs
Q90122490Assessment of Acute Motor Effects and Tolerance Following Self-Administration of Alcohol and Edible ∆9 -Tetrahydrocannabinol in Adolescent Male Mice
Q47670201Association between Nonmedical Marijuana and Pain Reliever Uses among Individuals Aged 50.
Q63684006Association of Cohort and Individual Substance Use With Risk of Transitioning to Drug Use, Drug Use Disorder, and Remission From Disorder
Q50421061Associations Between Personality Disorders and Cannabis Use and Cannabis Use Disorder: A Population-Based Twin Study
Q38619560Bars, Nightclubs, and Cancer Prevention: New Approaches to Reduce Young Adult Cigarette Smoking
Q33835356Biological substrates of addiction.
Q39131734Building smart cannabis policy from the science up.
Q38750716Can we make cannabis safer?
Q54967067Cannabidiol to Improve Mobility in People with Multiple Sclerosis.
Q92401471Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
Q39004651Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases
Q37630787Cannabis Epidemiology: A Selective Review.
Q44349195Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States
Q39150465Cannabis and Pain: A Clinical Review
Q42682870Cannabis and alcohol use, affect and impulsivity in psychiatric out-patients' daily lives
Q90626055Cannabis and mental illness: a review
Q92898356Cannabis and the Current State of Treatment for Cannabis Use Disorder
Q92310219Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives
Q41989040Cannabis for the Treatment of Chronic Pain in the Era of an Opioid Epidemic: A Symposium-Based Review of Sociomedical Science
Q88907845Cannabis regulatory science: risk-benefit considerations for mental disorders
Q37615283Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study
Q38711780Childhood traumatic experiences and the association with marijuana and cocaine use in adolescence through adulthood.
Q36117825Cigarette Smoking and Risk of Alcohol Use Relapse Among Adults in Recovery from Alcohol Use Disorders
Q101476198Cocaine addicted rats show reduced neural activity as revealed by manganese-enhanced MRI
Q37395047Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects
Q33865481Competing neurobehavioral decision systems theory of cocaine addiction: From mechanisms to therapeutic opportunities
Q36415071Concurrent treatment of posttraumatic stress disorder and alcohol dependence: Predictors and moderators of outcome
Q50654868Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
Q52317805Daily patterns of marijuana and alcohol co-use among individuals with alcohol and cannabis use disorders.
Q35838639Demographic and psychological factors associated with lifetime cocaine use: An exploratory factor analysis of baseline questionnaires
Q92262435Denying renal transplantation to an adolescent medical cannabis user: An ethical case study
Q47675654Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service
Q35859923Do placebo response rates from cessation trials inform on strength of addictions?
Q30366949Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed
Q34970338Dopamine D1 receptor gene variation modulates opioid dependence risk by affecting transition to addiction
Q57743948Doubling down: increased risk-taking behavior following a loss by individuals with cocaine use disorder is associated with striatal and anterior cingulate dysfunction
Q48065211Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial
Q99563502Drug use disorder following early life exposure to tetrachloroethylene (PCE)-contaminated drinking water: a retrospective cohort study
Q90191256Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder
Q41551230ELSA 2016 Cohort: Alcohol, Tobacco, and Marijuana Use and Their Association with Age of Drug Use Onset, Risk Perception, and Social Norms in Argentinean College Freshmen.
Q58101638Early Risk Factors for Daily Cannabis Use in Young Adults
Q45057395Early maturation and substance use across adolescence and young adulthood: A longitudinal study of Finnish twins
Q92718595Effect of adolescent androgen manipulation on psychosis-like behaviour in adulthood in BDNF heterozygous and control mice
Q38750739Effects of a brief, parent-focused intervention for substance using adolescents and their sibling
Q88789024Effects of amphetamine exposure during adolescence on behavior and prelimbic cortex neuron activity in adulthood
Q90357485Effects of chronic cannabinoid exposure during adolescence on reward preference and mPFC activation in adulthood
Q37200944Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions
Q33799805Epidemiology of substance use in reproductive-age women
Q39644977Estimated probability of becoming a case of drug dependence in relation to duration of drug-taking experience: a functional analysis approach
Q90452923Estimating Long-Term Drinking Patterns for People with Lifetime Alcohol Use Disorder
Q40247230Examining heterotypic continuity of psychopathology: a prospective national study
Q46180560Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC).
Q48220353Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being
Q60419105Female-male differences in alcohol dependence levels: Evidence on newly incident adolescent and young-adult drinkers in the United States, 2002-2014
Q52567089Frequency of Cannabis Use and Medical Cannabis Use Among Persons Living With HIV in the United States: Findings From a Nationally Representative Sample.
Q36001683Frequent marijuana use, binge drinking and mental health problems among undergraduates
Q33836185Gender and race/ethnicity differences for initiation of alcohol-related service use among persons with alcohol dependence
Q47810718Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study
Q36652144Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions
Q24289498Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings
Q92826769Genome-wide association study implicates CHRNA2 in cannabis use disorder
Q34303884Greater elevation in risk for nicotine dependence per pack of cigarettes smoked among those with an anxiety disorder.
Q89340947Impact of cannabis legalization on treatment and research priorities for cannabis use disorder
Q46563220Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats.
Q47115655Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users
Q90115713Insights into the role of cannabis in the management of inflammatory bowel disease
Q37129584Interaction between polygenic risk for cigarette use and environmental exposures in the Detroit Neighborhood Health Study
Q36833477Investigating Progression in Substance Use Initiation Using a Discrete-Time Multiple Event Process Survival Mixture (MEPSUM) Approach
Q47640713Investigating the mediational role of negative urgency in the anxiety sensitivity pathway to cannabis problems and dependence symptoms among postsecondary students.
Q34521105Keep off the grass? Cannabis, cognition and addiction
Q91973217Legalized Cannabis in Colorado Emergency Departments: A Cautionary Review of Negative Health and Safety Effects
Q37731162Long-lasting memory deficits in mice withdrawn from cocaine are concomitant with neuroadaptations in hippocampal basal activity, GABAergic interneurons and adult neurogenesis
Q60639478Longitudinal Methods in Substance Use Research
Q46924688Longitudinal Studies on the Etiology of Cannabis Use Disorder: A Review
Q37368453Longitudinal determinants of substance use disorders.
Q38740886Longitudinal relationships of sleep and inhibitory control deficits to early adolescent cigarette and alcohol use.
Q47637125Marijuana Use and Organ Transplantation: a Review and Implications for Clinical Practice.
Q33773395Marijuana Use, Recent Marijuana Initiation, and Progression to Marijuana Use Disorder Among Young Male and Female Adolescents Aged 12-14 Living in US Households
Q38824571Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys
Q28069855Medical cannabis - the Canadian perspective
Q90173408Medical cannabis for chronic pain: can it make a difference in pain management?
Q34570676Medical marijuana: more questions than answers
Q47903271Mental health differences between frequent cannabis users with and without dependence and the general population.
Q47232576Minding the brain: the role of pharmacotherapy in substance-use disorder treatment
Q36429054Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis
Q89873651Mu-opioid antagonism in the treatment of cannabis use disorder
Q55032013N-acetylcysteine: A potential treatment for substance use disorders.
Q36927776Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse
Q47943756Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study.
Q47344258Nicotine increases anterior insula activation to expected and unexpected outcomes among nonsmokers
Q38847765Pathways linking marijuana use to substance use problems among emerging adults: A prospective analysis of young Black men.
Q43075592Patterns of Marijuana Use in a 6-Month Pain Management Sample in the United States
Q37738986Patterns of marijuana and tobacco use associated with suboptimal self-rated health among US adult ever users of marijuana
Q39114732Peer Network Counseling as Brief Treatment for Urban Adolescent Heavy Cannabis Users
Q36368406Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders
Q60313531Personal experience and attitudes of pain medicine specialists in Israel regarding the medical use of cannabis for chronic pain
Q37679140Personality traits and vulnerability or resilience to substance use disorders.
Q36625746Predictors of quit attempts and successful quit attempts in a nationally representative sample of smokers.
Q33568885Prevalence & correlates of tobacco use among adolescents in Kerala, India.
Q37658318Prevalence and correlates of alcohol and cannabis use disorders in the United States: results from the national longitudinal study of adolescent health
Q41220943Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age.
Q47556136Prevalence of problematic cannabis use in Canada: Cross-sectional findings from the 2013 Canadian Tobacco, Alcohol and Drugs Survey.
Q47555908Prevalence, Diagnosis, and Treatment Rates of Mood Disorders among Opioid Users under Criminal Justice Supervision.
Q91578309Priming primary care providers to engage in evidence-based discussions about cannabis with patients
Q45902136Prior alcohol use enhances vulnerability to compulsive cocaine self-administration by promoting degradation of HDAC4 and HDAC5.
Q34435738Probability and predictors of the cannabis gateway effect: a national study
Q37128199Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the National Epidemiologic Survey on Alcohol and Related Conditions
Q36794523Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study.
Q64245770Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence
Q89685781Protocol for a feasibility study investigating the UCalgary's Cannabis Café: education and harm reduction initiative for postsecondary students
Q90734187Psychoactive substance use among outpatients with severe mental illness: A comparative study
Q36836847Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug?
Q38605561Race/ethnicity and marijuana use in the United States: Diminishing differences in the prevalence of use, 2006-2015.
Q34190594Race/ethnicity and sex differences in progression from drinking initiation to the development of alcohol dependence
Q40509840Rapid transition from drinking to alcohol dependence among adolescent and young-adult newly incident drinkers in the United States, 2002-2013.
Q37375052Rate of progression from first use to dependence on cocaine or opioids: a cross-substance examination of associated demographic, psychiatric, and childhood risk factors
Q50561199Rats quit nicotine for a sweet reward following an extensive history of nicotine use.
Q38599985Recent cannabis use among Veterans in the United States: Results from a national sample
Q39524644Recreational marijuana use is not associated with worse outcomes after renal transplantation.
Q37667076Relation among HPA and HPG neuroendocrine systems, transmissible risk and neighborhood quality on development of substance use disorder: results of a 10-year prospective study
Q34099638Risk factors for anxiety disorders: common and specific effects in a national sample
Q30316580Risks associated with the non-medicinal use of cannabis
Q49263953Scientific Evidence for the Addictiveness of Tobacco and Smoking Cessation in Tobacco Litigation
Q47573027Sex and gender differences in substance use disorders
Q36157017Sex differences in behavior and neural development and their role in adolescent vulnerability to substance use
Q89529732Sex- and Gender-Based Analysis in Cannabis Treatment Outcomes: A Systematic Review
Q38676035Shaping vulnerability to addiction - the contribution of behavior, neural circuits and molecular mechanisms.
Q34005873Stimulant dependence and stimulant-associated psychosis: clinical characteristics and age of onset in a native American community sample
Q30433321Stress modulates illness-course of substance use disorders: a translational review
Q59789689Subregional Hippocampal Thickness Abnormalities in Older Adults with a History of Heavy Cannabis Use
Q35636292Telling true from false: cannabis users show increased susceptibility to false memories
Q47552036Testing Genetic and Environmental Associations Between Personality Disorders and Cocaine Use: A Population-Based Twin Study
Q36702297Testing the drug substitution switching-addictions hypothesis. A prospective study in a nationally representative sample
Q36307812The Dutch Cannabis Dependence (CanDep) study on the course of frequent cannabis use and dependence: objectives, methods and sample characteristics.
Q53424578The Effects of Nicotine and Tobacco use on Brain Reward Function: Interaction with Nicotine Dependence Severity.
Q58707392The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity
Q90576570The Pediatrician and Marijuana: An Era of Change
Q38950639The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders
Q47705555The association between adolescent cannabis use and anxiety: A parallel process analysis
Q41105095The couple that smokes together: Dyadic marijuana use and relationship functioning during conflict.
Q50111626The emerging marijuana retail environment: Key lessons learned from tobacco and alcohol retail research.
Q64882775The impact of cohort substance use upon likelihood of transitioning through stages of alcohol and cannabis use and use disorder: Findings from the Australian National Survey on Mental Health and Wellbeing.
Q37281788The latent structure and predictors of non-medical prescription drug use and prescription drug use disorders: a national study.
Q62721385The pharmacokinetics and the pharmacodynamics of cannabinoids
Q52313456The potential impact of cannabis legalization on the development of cannabis use disorders.
Q35954701The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC).
Q35952070The role of decision-making in cannabis-related problems among young adults
Q89744537The role of negative affect in the persistence of nicotine dependence among alternative high school students: A latent growth curve analysis
Q55397242Therapeutic potential of medicinal marijuana: an educational primer for health care professionals.
Q90396906Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada
Q93363150Time since first cannabis use and 12-month prevalence of cannabis use disorder among youth and emerging adults in the United States
Q33924603Time to connect: bringing social context into addiction neuroscience
Q33852341Toward National Estimates of Effectiveness of Treatment for Substance Use
Q34617902Toward a comprehensive developmental model of smoking initiation and nicotine dependence
Q33607241Toward the Identification of a Specific Psychopathology of Substance Use Disorders
Q37640693Towards a comprehensive developmental model of cannabis use disorders
Q35855173Towards a comprehensive developmental model of pathological gambling
Q37274656Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis
Q88906456Transition to drug co-use among adolescent cannabis users: The role of decision-making and mental health
Q30697158Transitioning from First Drug Use to Dependence Onset: Illustration of a Multiparametric Approach for Comparative Epidemiology
Q91805014Transitions Through Stages of Alcohol Use, Use Disorder and Remission: Findings from Te Rau Hinengaro, The New Zealand Mental Health Survey
Q36384293Transitions in illicit drug use status over 3 years: a prospective analysis of a general population sample
Q52775809Trends in Daily Cannabis Use Among Cigarette Smokers: United States, 2002-2014.
Q38990044Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder
Q38635163Working memory and salivary brain-derived neurotrophic factor as developmental predictors of cocaine seeking in male and female rats.
Q91972249[Addictive behaviors: clinical facts]

Search more.